It has been announced that the collaboration between Summit Therapeutics and the University of Oxford working to develop Utrophin Modulators for the disorder DMD has been extended by 12 months.
Category:
It has been announced that the collaboration between Summit Therapeutics and the University of Oxford working to develop Utrophin Modulators for the disorder DMD has been extended by 12 months.